KUFER PETER has a total of 22 patent applications. Its first patent ever was published in 1998. It filed its patents most often in United States, WIPO (World Intellectual Property Organization) and Australia. Its main competitors in its focus markets biotechnology, pharmaceuticals and organic fine chemistry are ARTYMIUK PETER, HELION BIOTECH APS and DUECKER KLAUS.
# | Country | Total Patents | |
---|---|---|---|
#1 | United States | 12 | |
#2 | WIPO (World Intellectual Property Organization) | 4 | |
#3 | Australia | 3 | |
#4 | EPO (European Patent Office) | 2 | |
#5 | Canada | 1 |
# | Industry | |
---|---|---|
#1 | Biotechnology | |
#2 | Pharmaceuticals | |
#3 | Organic fine chemistry | |
#4 | Machines | |
#5 | Agriculture |
# | Technology | |
---|---|---|
#1 | Peptides | |
#2 | Therapeutic chemical compounds | |
#3 | Medical preparations | |
#4 | Measuring microorganism processes | |
#5 | Microorganisms | |
#6 | Combinatorial chemistry | |
#7 | Unspecified technologies | |
#8 | Animal care |
# | Name | Total Patents |
---|---|---|
#1 | Kufer Peter | 22 |
#2 | Kischel Roman | 10 |
#3 | Raum Tobias | 10 |
#4 | Lutterbuese Ralf | 7 |
#5 | Borschert Katrin | 6 |
#6 | Mangold Susanne | 6 |
#7 | Klinger Matthias | 5 |
#8 | Rau Doris | 5 |
#9 | Hoffmann Patrick | 4 |
#10 | Mecklenburg Ingo | 4 |
Publication | Filing date | Title |
---|---|---|
US2016208338A1 | Method of Treating a Patient or Exempting a Patient From Further Treatment Subsequent to Tumor Removal | |
AU2003294744A1 | Novel real-time rt-pcr for the sensitive detection of multiple mage gene transcripts | |
AU6015301A | Multifunctional polypeptides comprising a binding site to an epitope of the nkg2d receptor complex | |
AU1873199A | Method of identifying binding site domains that retain the capacity of binding to an epitope |